Diligence memo · auto-generated · as of July 2, 2026
Nerveda Llc
Nerveda Llc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Nerveda Llc operates in Biotechnology, based in SAN DIEGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Nerveda Llc has raised $18M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $14M on 2007-06-20.
Most recent recorded round closed around 2011-07-22.
Valuation (modeled)modeled
Provath models Nerveda Llc at approximately $141M (range $4.3M–$767M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.70× the median modeled value of Series A Biotechnology companies in 2010–2012 (92 peers) — value vs value, same stage and era. Within the normal band (70% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 49 months.
Last raise 14.9 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 3.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 66% of Biotechnology peers (4293 compared).
Modeled value ranks above 65% of those peers.
Closest niche peers: Tobira Therapeutics, Inc., Neoprobe Corp, Akebia Therapeutics, Inc., Adimab, LLC, Elevation Pharmaceuticals Inc.
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.